(FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | |
---|---|---|---|---|---|---|
Turnover | 59.50%188.66M | 56.83%74.67M | 39.11%118.29M | --47.61M | 62.51%85.03M | --52.32M |
Operating income | 59.50%188.66M | 56.83%74.67M | 39.11%118.29M | 47.61M | 62.51%85.03M | 52.32M |
Cost of sales | -94.76%-31.92M | 7.57%-9.58M | -81.28%-16.39M | ---10.36M | 33.01%-9.04M | ---13.5M |
Operating expenses | -94.76%-31.92M | 7.57%-9.58M | -81.28%-16.39M | -10.36M | 33.01%-9.04M | -13.5M |
Gross profit | 53.82%156.74M | 74.74%65.09M | 34.10%101.9M | 37.25M | 95.72%75.99M | 38.82M |
Selling expenses | -57.24%-29.15M | -166.00%-11.5M | 8.15%-18.54M | ---4.32M | -116.08%-20.18M | ---9.34M |
Administrative expenses | -136.68%-30.12M | -108.99%-10.09M | -21.32%-12.72M | ---4.83M | -21.37%-10.49M | ---8.64M |
Research and development expenses | -99.49%-9.77M | -235.10%-5.58M | 39.13%-4.9M | ---1.66M | -47.21%-8.05M | ---5.47M |
Revaluation surplus | 128.00%7.1M | ---- | 70.82%-25.36M | ---19.61M | -30.21%-86.89M | ---66.74M |
-Changes in the fair value of other assets | 128.00%7.1M | ---- | 70.82%-25.36M | ---19.61M | -30.21%-86.89M | ---66.74M |
Impairment and provision | 208.35%2.65M | 25.44%-3.15M | -731.01%-2.44M | ---4.22M | 109.09%387K | ---4.26M |
-Other impairment is provision | 208.35%2.65M | 25.44%-3.15M | -731.01%-2.44M | ---4.22M | 109.09%387K | ---4.26M |
Special items of operating profit | -121.58%-5.53M | -96.82%349K | 179.71%25.64M | --10.99M | 778.91%9.17M | --1.04M |
Operating profit | 44.57%91.92M | 158.40%35.12M | 258.66%63.58M | 13.59M | 26.57%-40.07M | -54.57M |
Financing cost | 7.32%-975K | 13.85%-541K | -62.85%-1.05M | ---628K | 36.23%-646K | ---1.01M |
Earning before tax | 45.44%90.94M | 166.74%34.58M | 253.56%62.53M | 12.97M | 26.75%-40.72M | -55.59M |
Tax | -1.57%-16.08M | -20.33%-7.58M | -77.07%-15.84M | ---6.3M | -102.01%-8.94M | ---4.43M |
After-tax profit from continuing operations | 60.32%74.86M | 305.01%27.01M | 194.02%46.69M | 6.67M | 17.25%-49.66M | -60.01M |
Earning after tax | 60.32%74.86M | 305.01%27.01M | 194.02%46.69M | 6.67M | 17.25%-49.66M | -60.01M |
Minority profit | 89.53%652K | 270.69%215K | -4.44%344K | --58K | 116.08%360K | ---2.24M |
Profit attributable to shareholders | 60.10%74.21M | 305.31%26.79M | 192.66%46.35M | 6.61M | 13.42%-50.02M | -57.77M |
Basic earnings per share | ||||||
Diluted earnings per share | ||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | -- | Hong Kong Lixin Dehao Certified Public Accountants Limited | Hong Kong Lixin Dehao Certified Public Accountants Limited |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data